Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
77.50    -0.90 (-1.15%)
Bid:
77.35
Ask:
77.45
Spread: 0.10 (0.129%)
Market Cap: £1.48b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

21 May 2025 07:00

RNS Number : 4823J
Coats Group PLC
21 May 2025
 

21 May 2025

Coats Group plc

Trading Update

 

Continued trading momentum - full-year outlook in line with expectations

 

Coats Group plc ('Coats', the 'Company' or the 'Group'), the world's leading industrial thread and global footwear component manufacturer, today announces a trading update for the four month period from 1 January to 30 April 2025 (the 'period') ahead of its Annual General Meeting to be held later today.

 

1 January to 30 April 2025 revenues vs same period in 2024

CER2

Reported

Apparel

5%

3%

Footwear

5%

4%

Performance Materials1

0%

-3%

Group1

4%

2%

 

1 Excluding US Yarns business

2 Constant exchange rate (CER) figures are 2024 results restated at 2025 exchange rates

 

All following references are at CER unless specified.

 

The Group delivered a good performance in the period with revenue up 4%, reflecting continued momentum in Apparel and Footwear which both achieved 5% year-on-year growth, building further on the recovery seen in 2024. Performance Materials traded in line with expectations, with revenue excluding US Yarns at a similar level to the same period last year, as subdued conditions continue to affect a number of key end markets.

 

In line with our medium-term financial framework, underlying Group EBIT margins continued to improve, with further efficiency gains funding investment in our growth drivers.

 

Following the closure of our plant in Toluca, Mexico in Q4 2024, we announced in April 2025 our intention to fully exit from the low-margin US Yarns business based in Kings Mountain, North Carolina. Earlier this month, we agreed to sell the business and assets of US Yarns, and this will generate net cash proceeds of around $16m, with completion expected in June 2025. The US Yarns business had sales of $68m and EBIT of $3m in 2024, and this exit will further improve the quality of the Coats portfolio as well as margins.

 

Outlook

 

Given the positive start to the year and our current order book visibility, we expect the first half performance to reflect an adjusted EBIT margin within our medium-term margin target range of 19-21%.

 

The recently announced US-led trade tariffs have created elevated uncertainty in a number of markets and we continue to monitor this situation closely. This remains a dynamic backdrop and consequently challenging at this point to determine any indirect impact on future demand, but we have been encouraged by the continued positive momentum through the period. The Group is a global market leader with a proven and resilient business model - with a global footprint, low capital intensity, a flexible cost base and proven pricing power - which continues to position us strongly to navigate any market volatility.

 

Whilst mindful of the dynamic backdrop, our full year expectations remain unchanged, with a broadly equal profit weighting across H1 and H2. We expect another year of strong free cash flow generation, supporting the Group's active and flexible capital allocation strategy. We continue to build a pipeline of attractive acquisition targets to further strengthen our portfolio, with the capacity to take advantage of any opportunities created by any disruption.

 

Commenting on the results David Paja, Group Chief Executive, said:

 

"We have traded well in the first few months of 2025 and we expect to finish the first half with performance ahead of the prior year, reflecting both growth and further margin expansion.

 

It is too early to be definitive on any longer-term impact from tariffs and trade restrictions but I am confident in the Group's ability to navigate different scenarios with a well-honed playbook, while continuing to invest in our growth initiatives. Our client relationships, global footprint and high-quality product portfolio will underpin the delivery of market leading growth and profitability, together with substantial and increasing free cash flow."

 

The Group will release its 2025 Interim Results on 31 July 2025.

 

Enquiry details

Investors

Anjali Kotak

Coats Group plc

+44 (0) 7880 471 350

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0) 20 3727 1374

 

 

About Coats Group plc

Coats is a world leader in thread manufacturing and structural components for apparel and footwear, as well as an innovative pioneer in performance materials. These critical solutions are used to create a wide range of products, including ones that provide safety and protection for people, data and the environment. Headquartered in the UK, Coats is a FTSE250 company and a FTSE4Good Index constituent. Revenue in 2024 was $1.5 billion.

Trusted by the world's leading companies to deliver crucial, innovative, and sustainable solutions, Coats provides value-adding products including apparel, accessory and footwear threads, structural footwear components, fabrics, yarns and software applications. Customer partners include companies from the apparel, footwear, automotive, telecoms, personal protection, and outdoor goods industries.

 

With a proud heritage dating back more than 250 years and a spirit of evolution to constantly stay ahead of changing market needs, Coats has operations across some 50 countries with a permanent workforce of more than 16,000, serving its customers worldwide.

 

Coats connects talent, textiles, and technology, to make a better and more sustainable world. Worldwide, there are four dedicated Coats Innovation Hubs, where experts collaborate with partners to create the materials and products of tomorrow. It participates in the UN Global Compact and is committed to validated Science Based sustainability targets for 2030 and beyond, with an aspiration of achieving net-zero by 2050. Coats is also committed to achieving

its goals in Diversity, Equity & Inclusion, workplace health & safety, employee & community wellbeing, and supplier social performance. To find out more about Coats visit www.coats.com.

 

Cautionary statement

Certain statements in this trading update are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements contain risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKKBQABKDPPB
Date   Source Headline
9th May 20252:33 pmRNSHolding(s) in Company
29th Apr 20251:26 pmRNSHolding(s) in Company
8th Apr 20252:58 pmRNSBlock listing Interim Review
7th Apr 20251:18 pmRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNSStrategic exit from US Yarns
21st Mar 20252:21 pmRNSDirector/PDMR Shareholding
17th Mar 20252:00 pmRNSDirector/PDMR Shareholding
13th Mar 20253:20 pmRNSDirector/PDMR Shareholding
13th Mar 20257:19 amRNSAnnual Financial Report
10th Mar 20254:02 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNS2024 Full Year Results
7th Jan 20257:00 amRNSDirectorate Change
2nd Jan 20259:00 amRNSDirector Declaration
17th Dec 20241:16 pmRNSDirector/PDMR Shareholding
16th Dec 202411:04 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSTrading Statement
15th Oct 202412:41 pmRNSBlock listing Interim Review
9th Oct 20243:16 pmRNSDirector/PDMR Shareholding
17th Sep 202411:11 amRNSHolding(s) in Company
16th Sep 20241:19 pmRNSHolding(s) in Company
12th Sep 20249:37 amRNSHolding(s) in Company
6th Sep 20242:00 pmRNSDirector/PDMR Shareholding
5th Sep 20242:00 pmRNSDirector Declaration
4th Sep 20247:00 amRNSFinal de-risking of UK pension scheme
13th Aug 20241:15 pmRNSHolding(s) in Company
12th Aug 20247:00 amRNSDirectorate Change
1st Aug 20247:00 amRNSHalf-year Report
30th May 20247:00 amRNSDirectorate Change
22nd May 20244:33 pmRNSResult of AGM
22nd May 20247:00 amRNSTrading Statement
7th May 20241:16 pmRNSHolding(s) in Company
5th Apr 202410:50 amRNSBlock listing Interim Review
25th Mar 20242:16 pmRNSDirector/PDMR Shareholding
25th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 20243:55 pmRNSAnnual Financial Report
8th Mar 202412:27 pmRNSDirector/PDMR Shareholding
8th Mar 202412:25 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNS2023 Full Year Results
29th Feb 202410:03 amRNSHolding(s) in Company
29th Feb 20249:59 amRNSHolding(s) in Company
14th Dec 20232:13 pmRNSDirector Declaration
7th Dec 20237:00 amRNSSwitch off of Pension Deficit Repair Payments
22nd Nov 20237:00 amRNSTrading Statement
21st Nov 20239:22 amRNSHolding(s) in Company
16th Nov 20232:02 pmRNSHolding(s) in Company
15th Nov 20239:00 amRNSChange of Senior Independent Director
1st Nov 20231:38 pmRNSHolding(s) in Company
9th Oct 202312:10 pmRNSBlock listing Interim Review
5th Oct 20237:00 amRNSDirectorate Change
27th Sep 202312:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.